Ligand Pharmaceuticals
LGND
#2733
Rank
NZ$11.17 B
Marketcap
NZ$558.59
Share price
2.60%
Change (1 day)
50.18%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): NZ$2.54

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$17.80. In 2022 the company made an earnings per share (EPS) of NZ-$3.52 a decrease over its 2021 EPS that were of NZ$6.15.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$2.54-172.07%
2022NZ-$3.52-157.23%
2021NZ$6.15-2571.43%
2020NZ-$0.25-100.46%
2019NZ$54.43353.48%
2018NZ$12.001025%
2017NZ$1.07-700%
2016NZ-$0.18-100.87%
2015NZ$20.551859.32%
2014NZ$1.055.36%
2013NZ$1.008.0704505322479E+18%
2012NZ$0.0000000000-100%
2011NZ$0.87-194.23%
2010NZ-$0.92548.38%
2009NZ-$0.14-98.7%
2008NZ-$10.99-136.52%
2007NZ$30.09-787.8%
2006NZ-$4.37-14.58%
2005NZ-$5.12-21.31%
2004NZ-$6.51-55.15%
2003NZ-$14.5181.33%
2002NZ-$8.002.74%
2001NZ-$7.79-45.93%
2000NZ-$14.40-14.56%
1999NZ-$16.86-45.52%
1998NZ-$30.94-3.97%
1997NZ-$32.22132.31%
1996NZ-$13.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.89-33.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.35-92.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.88 208.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.84 62.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$2.51-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.77-90.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.04-54.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.12-71.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ-$0.64-103.60%๐Ÿ‡บ๐Ÿ‡ธ USA